Servier is a global pharmaceutical group present in 150 countries and employing 22,500 people worldwide. Servier is an independent group, governed by a non-profit foundation and invests over 20% of its brand-name revenue in Research and Development every year. Committed to accelerate therapeutic innovation to serve patients, the Servier Group focuses on cardiovascular and metabolic diseases, oncology, neuropsychiatric and venous diseases. To promote access to healthcare for all, the Group also offers a range of quality generic drugs covering most pathologies. In 2020, the Servier Group achieved a revenue of 4.7 billion in 150 countries. Servier is certified Top Employer Europe 2021.